Clinical Trials for Antibody Mediated Rejection of Lung Transplant

Find clinical trials for antibody mediated rejection of lung transplant. Discover research opportunities and treatment options in your area.

1 Active Trial Found

Showing 1 trial on this page

Page 1 of 1

A Phase 1 Clinical Trial of Siltuximab for the Treatment of Antibody-Mediated Rejection After Lung Transplantation

NCT ID: NCT06990711

This clinical trial is looking at a new treatment called Siltuximab for patients who have experienced antibody-mediated rejection after receiving a lung transplant. Antibody-mediated rejection can ...

Not yet recruiting

Phase: PHASE1 Type: interventional Locations: St. Louis, Missouri, United States, St. Lake City, Utah, United States

Related Conditions

Breast Cancer View clinical trials → Stroke View clinical trials → Obesity View clinical trials → Cancer View clinical trials → Healthy View clinical trials → Prostate Cancer View clinical trials →

Search All Trials Browse All Conditions